A randomized, double-blind, placebo-controlled phase 1 clinical trial of MLN0415 in healthy volunteers to assess safety, tolerability, pharmacokinetic and pharmacodynamic effects
Latest Information Update: 05 Sep 2006
At a glance
- Drugs MLN 0415 (Primary)
- Indications Arthritis; Inflammation; Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Takeda Oncology
- 05 Sep 2006 New trial record.